Jul 14, 2026 09:16AM
Jul 14, 2026 09:16AM
Jul 13, 2026 07:01AM
Jul 13, 2026 07:00AM
Jul 6, 2026 07:00AM
Jul 6, 2026 07:00AM
Jun 25, 2026 07:12AM Needham Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
Jun 25, 2026 06:48AM
Jun 25, 2026 03:33AM
Jun 25, 2026 02:59AM
Jun 25, 2026 02:59AM
Jun 24, 2026 02:39PM
Jun 24, 2026 02:37PM
Jun 4, 2026 07:00AM Ionis to present new analyses from CORE and CORE2 pivotal studies supporting olezarsen for severe hypertriglyceridemia (sHTG) at upcoming congresses
Jun 1, 2026 06:57AM
May 28, 2026 04:45AM
May 14, 2026 07:05AM
May 14, 2026 07:05AM
Apr 29, 2026 07:00AM
Apr 28, 2026 02:06AM
Apr 28, 2026 02:06AM Ionis partner GSK announces bepirovirsen accepted for Priority Review and granted Breakthrough Therapy Designation by U.S. FDA as a potential first-in-class medicine for chronic hepatitis B
Apr 21, 2026 07:03AM
Apr 21, 2026 07:00AM
Mar 30, 2026 07:30AM
Mar 30, 2026 07:30AM
Mar 23, 2026 07:00AM
Mar 23, 2026 07:00AM
Mar 9, 2026 07:00AM Ionis announces board changes with two retirements, one addition
Mar 9, 2026 07:00AM
Mar 5, 2026 07:30AM
Feb 26, 2026 07:00AM
Feb 26, 2026 07:00AM
Feb 26, 2026 07:00AM
Feb 25, 2026 01:20PM
Feb 25, 2026 07:00AM Ionis reports fourth quarter and full year 2025 financial results and highlights progress on key programs
Feb 4, 2026 07:30AM
Feb 4, 2026 07:30AM
Jan 21, 2026 07:00AM
Jan 21, 2026 07:00AM
Jan 12, 2026 11:06AM
Jan 12, 2026 11:05AM
Jan 12, 2026 07:00AM Ionis well-positioned for continued momentum and substantial value creation in 2026 with two new independent launches and several pivotal data readouts
Jan 7, 2026 02:15AM
Jan 7, 2026 02:15AM
Dec 2, 2025 07:00AM
Dec 2, 2025 07:00AM
Dec 1, 2025 07:01AM
Dec 1, 2025 07:00AM
Nov 17, 2025 06:02AM Biogen (BIIB): High Dose Regimen of Nusinersen Receives Positive CHMP Opinion for the Treatment of Spinal Muscular Atrophy
Nov 17, 2025 06:00AM

325,888 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All